Seguir
Mark Voigt
Mark Voigt
Dirección de correo verificada de slu.edu
Título
Citado por
Citado por
Año
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits
BS Khakh, G Burnstock, C Kennedy, BF King, RA North, P Séguéla, ...
Pharmacological reviews 53 (1), 107-118, 2001
8432001
Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells
P Werner, M Voigt, K Keinänen, W Wisden, PH Seeburg
Nature 351 (6329), 742-744, 1991
6041991
Hetero-oligomeric assembly of P2X receptor subunits: specificities exist with regard to possible partners
GE Torres, TM Egan, MM Voigt
Journal of Biological Chemistry 274 (10), 6653-6659, 1999
5331999
Molecular cloning and characterization of a rat brain cDNA encoding a 5‐hydroxytryptamine1B receptor.
MM Voigt, DJ Laurie, PH Seeburg, A Bach
The EMBO journal 10 (13), 4017-4023, 1991
2761991
Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain
SK McCune, MM Voigt, JM Hill
Neuroscience 57 (1), 143-151, 1993
2311993
Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel
GE Torres, WR Haines, TM Egan, MM Voigt
Molecular pharmacology 54 (6), 989-993, 1998
2091998
A domain contributing to the ion channel of ATP-gated P2X2 receptors identified by the substituted cysteine accessibility method
TM Egan, WR Haines, MM Voigt
Journal of Neuroscience 18 (7), 2350-2359, 1998
1701998
Sequence of a rat brain cDNA encoding an alpha-1B adrenergic receptor.
MM Voigt, J Kispert, HM Chin
Nucleic acids research 18 (4), 1053, 1990
1361990
Properties of the novel ATP-gated ionotropic receptor composed of the P2X1 and P2X5 isoforms
WR Haines, GE Torres, MM Voigt, TM Egan
Molecular pharmacology 56 (4), 720-727, 1999
1101999
Molecular characterization of the zebrafish P2X receptor subunit gene family
S Kucenas, Z Li, JA Cox, TM Egan, MM Voigt
Neuroscience 121 (4), 935-945, 2003
1072003
In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin
MM Voigt, RY Wang
Brain research 296 (1), 189-193, 1984
1061984
Polar residues of the second transmembrane domain influence cation permeability of the ATP-gated P2X2 receptor
K Migita, WR Haines, MM Voigt, TM Egan
Journal of Biological Chemistry 276 (33), 30934-30941, 2001
1022001
Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro.
M Voigt, RY Wang, TC Westfall
Journal of Pharmacology and Experimental Therapeutics 237 (1), 147-153, 1986
1011986
Identification of a domain involved in ATP-gated ionotropic receptor subunit assembly
GE Torres, TM Egan, MM Voigt
Journal of Biological Chemistry 274 (32), 22359-22365, 1999
1001999
Molecular characterization and embryonic expression of the family of N‐methyl‐D‐aspartate receptor subunit genes in the zebrafish
JA Cox, S Kucenas, MM Voigt
Developmental Dynamics 234 (3), 756-766, 2005
982005
Cloning and characterization of the rat 5‐HT5B receptor: Evidence that the 5‐HT5B receptor couples to a G protein in mammalian cell membranes
W Wisden, EM Parker, CD Mahle, DA Grisel, HP Nowak, FD Yocca, ...
FEBS letters 333 (1-2), 25-31, 1993
971993
N-Linked glycosylation is essential for the functional expression of the recombinant P2X2 receptor
GE Torres, TM Egan, MM Voigt
Biochemistry 37 (42), 14845-14851, 1998
931998
Topological analysis of the ATP‐gated ionotrophic P2X2 receptor subunit
GE Torres, TM Egan, MM Voigt
FEBS letters 425 (1), 19-23, 1998
911998
The effects of cholecystokinin on the in vivo release of newly synthesized [3H] dopamine from the nucleus accumbens of the rat
MM Voigt, RY Wang, TC Westfall
Journal of Neuroscience 5 (10), 2744-2749, 1985
731985
Gain and loss of channel function by alanine substitutions in the transmembrane segments of the rat ATP-gated P2X2 receptor
Z Li, K Migita, DSK Samways, MM Voigt, TM Egan
Journal of Neuroscience 24 (33), 7378-7386, 2004
692004
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20